Risperdal Lawsuits Progress Several plaintiffs who have filed Risperdal lawsuits alleging gynecomastia and other complications have requested a judge overseeing hundreds of cases in Pennsylvania to consider individual […]
Risperdal Settlement According to the Montana Attorney General’s Office, a Risperdal settlement has been reached for more than $5.9 million. Janssen Pharmaceuticals and Johnson & Johnson reached the […]
Many people can find comfort in the chaos of mental illness with the assistance of pharmaceuticals. However, many of these drugs are reportedly severe in the way they […]
The U.S. Food and Drug Administration (FDA) has recently taken the spotlight as the agency continues its fight against pharmaceutical drug misbranding. While some critics claim that acting […]
Johnson & Johnson has asked that a Pennsylvania state judge keep documents pertaining to the results of clinical studies sealed in pending lawsuits pertaining to Risperdal, a highly-criticized […]
Risperdal was approved by the U.S. Food and Drug Administration (FDA) to treat schizophrenia, bipolar disorder and autism. Risperdal, an atypical anti-psychotic medication, is marketed and manufactured by […]